Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/08/603   
Active ingredient: Pralatrexate
Indication: Treatment of non-papillary transitional cell carcinoma of the urinary bladder
Sponsor: Allos Therapeutics Limited
71 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2009 Orphan designation EMEA/OD/074/08 (2009)389 of 19/01/2009
18/02/2010 Transfer of orphan designation EMEA/OD/074/08/T/01 (2010)965 of 12/02/2010
18/08/2010 Change of name and/or address of sponsor EMA/408875/2010